0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antidote Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-19R2416
Home | Market Reports | Law & Government| Public Safety
China Antidote Market Report Forecast 2021 2027
BUY CHAPTERS

Global Antidote Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-19R2416
Report
September 2022
114 Pages
QYResearch
Region: Global, Europe, North America, Japan, China
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Antidote market is projected to reach US$ 10440 million by 2028 from an estimated US$ 8690.8 million in 2022, at a CAGR of 3.1% during 2023 and 2028.

Global Antidote key players include Roche, Pfizer, Bayer, etc. Global top three manufacturers hold a share about 15%.

North America is the largest market, with a share about 35%, followed by Europe and China, both have a share about 50 percent.
In terms of product, Chemical Antidotes is the largest segment, with a share about 45%. And in terms of application, the largest application is Pesticide Poisoning, followed by Heavy Metal Poisoning.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antidote, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Antidote.
The Antidote market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Antidote market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antidote companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Roche
Pfizer
Bayer
Johnson & Johnson
Novartis
Eli Lilly
Teva
Boehringer Ingelheim
Mylan
Fresenius Kabi
Baxter
Furen Pharmaceutical
Product Type Insights
Global markets are presented by Antidote type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Antidote are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Antidote Segment by Type

Chemical Antidotes
Physical Antidotes
Pharmacological Antidotes
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Antidote market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Antidote market.

Antidote Segment by Application

Pesticide Poisoning
Heavy Metal Poisoning
Animal Bites Poisoning
Cyanide Poisoning
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antidote market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidote market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Antidote and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Antidote industry.
This report helps stakeholders to gain insights into which regions to target globally.
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidote.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

1 Study Coverage
1.1 Antidote Product Introduction
1.2 Market by Type
1.2.1 Global Antidote Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Chemical Antidotes
1.2.3 Physical Antidotes
1.2.4 Pharmacological Antidotes
1.3 Market by Application
1.3.1 Global Antidote Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Pesticide Poisoning
1.3.3 Heavy Metal Poisoning
1.3.4 Animal Bites Poisoning
1.3.5 Cyanide Poisoning
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antidote Market Size Estimates and Forecasts
2.2 Antidote Market Size by Region: 2022 Versus 2028
2.2.1 Global Antidote Revenue by Region: 2017-2022
2.2.2 Global Antidote Revenue Forecast by Region (2023-2028)
2.2.3 Global Antidote Revenue Market Share by Region (2017-2028)
3 Global Antidote by Company
3.1 Global Antidote Revenue by Company (2017-2022)
3.2 Global Antidote Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Antidote Companies around the World: Ranking by Revenue
3.3.2 Global Antidote Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Antidote Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Antidote Companies Headquarters & Product Type
3.4.1 Antidote Companies Headquarters
3.4.2 Global Antidote Companies Product & Service
3.4.3 Date of International Companies Enter into Antidote Market
3.5 Global Antidote Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Roche
4.1.1 Roche Corporation Information
4.1.2 Roche Description, Business Overview
4.1.3 Roche Antidote Products Offered
4.1.4 Roche Antidote Revenue and Gross Margin (2017-2022)
4.1.5 Roche Antidote Revenue by Product in 2021
4.1.6 Roche Antidote Revenue by Application in 2021
4.1.7 Roche Antidote Revenue by Geographic Area in 2021
4.1.8 Roche Recent Developments
4.2 Pfizer
4.2.1 Pfizer Corporation Information
4.2.2 Pfizer Description, Business Overview
4.2.3 Pfizer Antidote Products Offered
4.2.4 Pfizer Antidote Revenue and Gross Margin (2017-2022)
4.2.5 Pfizer Antidote Revenue by Product in 2021
4.2.6 Pfizer Antidote Revenue by Application in 2021
4.2.7 Pfizer Antidote Revenue by Geographic Area in 2021
4.2.8 Pfizer Recent Developments
4.3 Bayer
4.3.1 Bayer Corporation Information
4.3.2 Bayer Description, Business Overview
4.3.3 Bayer Antidote Products Offered
4.3.4 Bayer Antidote Revenue and Gross Margin (2017-2022)
4.3.5 Bayer Antidote Revenue by Product in 2021
4.3.6 Bayer Antidote Revenue by Application in 2021
4.3.7 Bayer Antidote Revenue by Geographic Area in 2021
4.3.8 Bayer Recent Developments
4.4 Johnson & Johnson
4.4.1 Johnson & Johnson Corporation Information
4.4.2 Johnson & Johnson Description, Business Overview
4.4.3 Johnson & Johnson Antidote Products Offered
4.4.4 Johnson & Johnson Antidote Revenue and Gross Margin (2017-2022)
4.4.5 Johnson & Johnson Antidote Revenue by Product in 2021
4.4.6 Johnson & Johnson Antidote Revenue by Application in 2021
4.4.7 Johnson & Johnson Antidote Revenue by Geographic Area in 2021
4.4.8 Johnson & Johnson Recent Developments
4.5 Novartis
4.5.1 Novartis Corporation Information
4.5.2 Novartis Description, Business Overview
4.5.3 Novartis Antidote Products Offered
4.5.4 Novartis Antidote Revenue and Gross Margin (2017-2022)
4.5.5 Novartis Antidote Revenue by Product in 2021
4.5.6 Novartis Antidote Revenue by Application in 2021
4.5.7 Novartis Antidote Revenue by Geographic Area in 2021
4.5.8 Novartis Recent Developments
4.6 Eli Lilly
4.6.1 Eli Lilly Corporation Information
4.6.2 Eli Lilly Description, Business Overview
4.6.3 Eli Lilly Antidote Products Offered
4.6.4 Eli Lilly Antidote Revenue and Gross Margin (2017-2022)
4.6.5 Eli Lilly Antidote Revenue by Product in 2021
4.6.6 Eli Lilly Antidote Revenue by Application in 2021
4.6.7 Eli Lilly Antidote Revenue by Geographic Area in 2021
4.6.8 Eli Lilly Recent Development
4.7 Teva
4.7.1 Teva Corporation Information
4.7.2 Teva Description, Business Overview
4.7.3 Teva Antidote Products Offered
4.7.4 Teva Antidote Revenue and Gross Margin (2017-2022)
4.7.5 Teva Antidote Revenue by Product in 2021
4.7.6 Teva Antidote Revenue by Application in 2021
4.7.7 Teva Antidote Revenue by Geographic Area in 2021
4.7.8 Teva Recent Development
4.8 Boehringer Ingelheim
4.8.1 Boehringer Ingelheim Corporation Information
4.8.2 Boehringer Ingelheim Description, Business Overview
4.8.3 Boehringer Ingelheim Antidote Products Offered
4.8.4 Boehringer Ingelheim Antidote Revenue and Gross Margin (2017-2022)
4.8.5 Boehringer Ingelheim Antidote Revenue by Product in 2021
4.8.6 Boehringer Ingelheim Antidote Revenue by Application in 2021
4.8.7 Boehringer Ingelheim Antidote Revenue by Geographic Area in 2021
4.8.8 Boehringer Ingelheim Recent Development
4.9 Mylan
4.9.1 Mylan Corporation Information
4.9.2 Mylan Description, Business Overview
4.9.3 Mylan Antidote Products Offered
4.9.4 Mylan Antidote Revenue and Gross Margin (2017-2022)
4.9.5 Mylan Antidote Revenue by Product in 2021
4.9.6 Mylan Antidote Revenue by Application in 2021
4.9.7 Mylan Antidote Revenue by Geographic Area in 2021
4.9.8 Mylan Recent Development
4.10 Fresenius Kabi
4.10.1 Fresenius Kabi Corporation Information
4.10.2 Fresenius Kabi Description, Business Overview
4.10.3 Fresenius Kabi Antidote Products Offered
4.10.4 Fresenius Kabi Antidote Revenue and Gross Margin (2017-2022)
4.10.5 Fresenius Kabi Antidote Revenue by Product in 2021
4.10.6 Fresenius Kabi Antidote Revenue by Application in 2021
4.10.7 Fresenius Kabi Antidote Revenue by Geographic Area in 2021
4.10.8 Fresenius Kabi Recent Development
4.11 Baxter
4.11.1 Baxter Corporation Information
4.11.2 Baxter Description, Business Overview
4.11.3 Baxter Antidote Products Offered
4.11.4 Baxter Antidote Revenue and Gross Margin (2017-2022)
4.11.5 Baxter Antidote Revenue by Product in 2021
4.11.6 Baxter Antidote Revenue by Application in 2021
4.11.7 Baxter Antidote Revenue by Geographic Area in 2021
4.11.8 Baxter Recent Development
4.12 Furen Pharmaceutical
4.12.1 Furen Pharmaceutical Corporation Information
4.12.2 Furen Pharmaceutical Description, Business Overview
4.12.3 Furen Pharmaceutical Antidote Products Offered
4.12.4 Furen Pharmaceutical Antidote Revenue and Gross Margin (2017-2022)
4.12.5 Furen Pharmaceutical Antidote Revenue by Product in 2021
4.12.6 Furen Pharmaceutical Antidote Revenue by Application in 2021
4.12.7 Furen Pharmaceutical Antidote Revenue by Geographic Area in 2021
4.12.8 Furen Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Antidote Revenue by Type (2017-2022)
5.2 Global Antidote Revenue Forecast by Type (2023-2028)
5.3 Antidote Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Antidote Revenue by Application (2017-2022)
6.2 Global Antidote Revenue Forecast by Application (2023-2028)
6.3 Antidote Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Antidote Market Size YoY Growth 2017-2028
7.2 North America Antidote Market Facts & Figures by Country (2017-2028)
7.3 North America Antidote Revenue by Type (2017-2022)
7.4 North America Antidote Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Antidote Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Antidote Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Antidote Revenue by Type (2017-2022)
8.4 Asia-Pacific Antidote Revenue by Application (2017-2022)
9 Europe
9.1 Europe Antidote Market Size YoY Growth 2017-2028
9.2 Europe Antidote Market Facts & Figures by Country (2017-2028)
9.3 Europe Antidote Revenue by Type (2017-2022)
9.4 Europe Antidote Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Antidote Market Size YoY Growth 2017-2028
10.2 Latin America Antidote Market Facts & Figures by Country (2017-2028)
10.3 Latin America Antidote Revenue by Type (2017-2022)
10.4 Latin America Antidote Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Antidote Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Antidote Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Antidote Revenue by Type (2017-2022)
11.4 Middle East and Africa Antidote Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Antidote Supply Chain Analysis
12.2 Antidote Key Raw Materials and Upstream Suppliers
12.3 Antidote Clients Analysis
12.4 Antidote Sales Channel and Sales Model Analysis
12.4.1 Antidote Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Antidote Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Antidote Distributors
13 Market Dynamics
13.1 Antidote Industry Trends
13.2 Antidote Market Drivers
13.3 Antidote Market Challenges
13.4 Antidote Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Antidote Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Companies of Chemical Antidotes
    Table 3. Major Companies of Physical Antidotes
    Table 4. Major Companies of Pharmacological Antidotes
    Table 5. Global Antidote Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Antidote Market Size by Region (US$ Million): 2022 VS 2028
    Table 7. Global Antidote Revenue by Region (2017-2022) & (US$ Million)
    Table 8. Global Antidote Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 9. Antidote Revenue by Company (2017-2022) & (US$ Million)
    Table 10. Antidote Revenue Share by Company (2017-2022)
    Table 11. Ranking of Global Top Antidote Players by Revenue (US$ Million) in 2021
    Table 12. Global Antidote Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 13. Global Antidote by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidote as of 2021)
    Table 14. Global Antidote Companies Headquarters
    Table 15. Global Antidote Companies Product & Service
    Table 16. Date of International Companies Enter into Antidote Market
    Table 17. Global Antidote Mergers & Acquisitions, Expansion Plans
    Table 18. Roche Corporation Information
    Table 19. Roche Description and Business Overview
    Table 20. Roche Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 21. Roche Antidote Product
    Table 22. Roche Antidote Revenue Proportion of Antidote by Product in 2021
    Table 23. Roche Antidote Revenue Proportion of Antidote by Application in 2021
    Table 24. Roche Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 25. Roche Recent Development
    Table 26. Pfizer Corporation Information
    Table 27. Pfizer Description and Business Overview
    Table 28. Pfizer Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 29. Pfizer Antidote Product
    Table 30. Pfizer Antidote Revenue Proportion of Antidote by Product in 2021
    Table 31. Pfizer Antidote Revenue Proportion of Antidote by Application in 2021
    Table 32. Pfizer Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 33. Pfizer Recent Development
    Table 34. Bayer Corporation Information
    Table 35. Bayer Description and Business Overview
    Table 36. Bayer Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 37. Bayer Antidote Product
    Table 38. Bayer Antidote Revenue Proportion of Antidote by Product in 2021
    Table 39. Bayer Antidote Revenue Proportion of Antidote by Application in 2021
    Table 40. Bayer Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 41. Bayer Recent Development
    Table 42. Johnson & Johnson Corporation Information
    Table 43. Johnson & Johnson Description and Business Overview
    Table 44. Johnson & Johnson Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 45. Johnson & Johnson Antidote Product
    Table 46. Johnson & Johnson Antidote Revenue Proportion of Antidote by Product in 2021
    Table 47. Johnson & Johnson Antidote Revenue Proportion of Antidote by Application in 2021
    Table 48. Johnson & Johnson Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 49. Johnson & Johnson Recent Development
    Table 50. Novartis Corporation Information
    Table 51. Novartis Description and Business Overview
    Table 52. Novartis Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 53. Novartis Antidote Product
    Table 54. Novartis Antidote Revenue Proportion of Antidote by Product in 2021
    Table 55. Novartis Antidote Revenue Proportion of Antidote by Application in 2021
    Table 56. Novartis Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 57. Novartis Recent Development
    Table 58. Eli Lilly Corporation Information
    Table 59. Eli Lilly Description and Business Overview
    Table 60. Eli Lilly Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 61. Eli Lilly Antidote Product
    Table 62. Eli Lilly Antidote Revenue Proportion of Antidote by Product in 2021
    Table 63. Eli Lilly Antidote Revenue Proportion of Antidote by Application in 2021
    Table 64. Eli Lilly Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 65. Teva Corporation Information
    Table 66. Teva Description and Business Overview
    Table 67. Teva Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 68. Teva Antidote Product
    Table 69. Teva Antidote Revenue Proportion of Antidote by Product in 2021
    Table 70. Teva Antidote Revenue Proportion of Antidote by Application in 2021
    Table 71. Teva Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 72. Boehringer Ingelheim Corporation Information
    Table 73. Boehringer Ingelheim Description and Business Overview
    Table 74. Boehringer Ingelheim Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 75. Boehringer Ingelheim Antidote Product
    Table 76. Boehringer Ingelheim Antidote Revenue Proportion of Antidote by Product in 2021
    Table 77. Boehringer Ingelheim Antidote Revenue Proportion of Antidote by Application in 2021
    Table 78. Boehringer Ingelheim Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 79. Mylan Corporation Information
    Table 80. Mylan Description and Business Overview
    Table 81. Mylan Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 82. Mylan Antidote Product
    Table 83. Mylan Antidote Revenue Proportion of Antidote by Product in 2021
    Table 84. Mylan Antidote Revenue Proportion of Antidote by Application in 2021
    Table 85. Mylan Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 86. Fresenius Kabi Corporation Information
    Table 87. Fresenius Kabi Description and Business Overview
    Table 88. Fresenius Kabi Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 89. Fresenius Kabi Antidote Product
    Table 90. Fresenius Kabi Antidote Revenue Proportion of Antidote by Product in 2021
    Table 91. Fresenius Kabi Antidote Revenue Proportion of Antidote by Application in 2021
    Table 92. Fresenius Kabi Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 93. Baxter Corporation Information
    Table 94. Baxter Description and Business Overview
    Table 95. Baxter Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 96. Baxter Antidote Product
    Table 97. Baxter Antidote Revenue Proportion of Antidote by Product in 2021
    Table 98. Baxter Antidote Revenue Proportion of Antidote by Application in 2021
    Table 99. Baxter Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 100. Furen Pharmaceutical Corporation Information
    Table 101. Furen Pharmaceutical Description and Business Overview
    Table 102. Furen Pharmaceutical Antidote Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 103. Furen Pharmaceutical Antidote Product
    Table 104. Furen Pharmaceutical Antidote Revenue Proportion of Antidote by Product in 2021
    Table 105. Furen Pharmaceutical Antidote Revenue Proportion of Antidote by Application in 2021
    Table 106. Furen Pharmaceutical Antidote Revenue Proportion of Antidote by Geographic Area in 2021
    Table 107. Global Antidote Revenue by Type (2017-2022) & (US$ Million)
    Table 108. Global Antidote Revenue by Application (2017-2022) & (US$ Million)
    Table 109. Global Antidote Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 110. North America Antidote Revenue by Country (2017-2022) & (US$ Million)
    Table 111. North America Antidote Revenue by Country (2023-2028) & (US$ Million)
    Table 112. North America Antidote Revenue by Type (2017-2022) & (US$ Million)
    Table 113. North America Antidote Revenue by Application (2017-2022) & (US$ Million)
    Table 114. Asia-Pacific Antidote Revenue by Region (2017-2028) & (US$ Million)
    Table 115. Asia-Pacific Antidote Revenue by Region (2023-2028) & (US$ Million)
    Table 116. Asia-Pacific Antidote Revenue by Type (2017-2022) & (US$ Million)
    Table 117. Asia-Pacific Antidote Revenue by Application (2017-2022) & (US$ Million)
    Table 118. Europe Antidote Revenue by Country (2017-2022) & (US$ Million)
    Table 119. Europe Antidote Revenue by Country (2023-2028) & (US$ Million)
    Table 120. Europe Antidote Revenue by Type (2017-2022) & (US$ Million)
    Table 121. Europe Antidote Revenue by Application (2017-2022) & (US$ Million)
    Table 122. Latin America Antidote Revenue by Country (2017-2022) & (US$ Million)
    Table 123. Latin America Antidote Revenue by Country (2023-2028) & (US$ Million)
    Table 124. Latin America Antidote Revenue by Type (2017-2022) & (US$ Million)
    Table 125. Latin America Antidote Revenue by Application (2017-2022) & (US$ Million)
    Table 126. Middle East and Africa Antidote Revenue by Country (2017-2022) & (US$ Million)
    Table 127. Middle East and Africa Antidote Revenue by Country (2023-2028) & (US$ Million)
    Table 128. Middle East and Africa Antidote Revenue by Type (2017-2022) & (US$ Million)
    Table 129. Middle East and Africa Antidote Revenue by Application (2017-2022) & (US$ Million)
    Table 130. Antidote Key Raw Materials, Industry Status and Trend
    Table 131. Antidote Key Raw Materials and Upstream Suppliers
    Table 132. Antidote Clients Status and Trend
    Table 133. Antidote Typical Clients
    Table 134. Antidote Distributors
    Table 135. Antidote Market Trends
    Table 136. Antidote Market Drivers
    Table 137. Antidote Market Challenges
    Table 138. Antidote Market Restraints
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antidote Product Picture
    Figure 2. Global Antidote Revenue Market Share by Type in 2021 & 2028
    Figure 3. Chemical Antidotes Product Picture
    Figure 4. Physical Antidotes Product Picture
    Figure 5. Pharmacological Antidotes Product Picture
    Figure 6. Global Antidote Revenue Market Share by Application in 2021 & 2028
    Figure 7. Pesticide Poisoning
    Figure 8. Heavy Metal Poisoning
    Figure 9. Animal Bites Poisoning
    Figure 10. Cyanide Poisoning
    Figure 11. Others
    Figure 12. Antidote Report Years Considered
    Figure 13. Global Antidote Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Antidote Market Size 2017-2028 (US$ Million)
    Figure 15. Global Antidote Market Size Market Share by Region: 2022 Versus 2028
    Figure 16. Global Antidote Revenue Market Share by Region (2017-2028)
    Figure 17. Antidote Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Antidote Revenue Market Share Forecast by Type (2017-2028)
    Figure 19. Global Antidote Revenue Market Share Forecast by Application (2017-2028)
    Figure 20. North America Antidote Revenue 2017-2028 (US$ Million)
    Figure 21. North America Antidote Revenue Market Share by Type (2017-2022)
    Figure 22. North America Antidote Revenue Market Share by Application (2017-2022)
    Figure 23. Asia-Pacific Antidote Revenue 2017-2028 (US$ Million)
    Figure 24. Asia-Pacific Antidote Revenue Market Share by Region (2017-2028)
    Figure 25. Asia-Pacific Antidote Revenue Market Share by Type (2017-2022)
    Figure 26. Asia-Pacific Antidote Revenue Market Share by Application (2017-2022)
    Figure 27. Europe Antidote Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 28. Europe Antidote Revenue Market Share by Country (2017-2028)
    Figure 29. Europe Antidote Revenue Market Share by Type (2017-2022)
    Figure 30. Europe Antidote Revenue Market Share by Application (2017-2022)
    Figure 31. Latin America Antidote Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 32. Latin America Antidote Revenue Market Share by Country (2017-2022)
    Figure 33. Latin America Antidote Revenue Market Share by Type (2017-2022)
    Figure 34. Latin America Antidote Revenue Market Share by Application (2017-2022)
    Figure 35. Middle East and Africa Antidote Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 36. Middle East and Africa Antidote Revenue Market Share by Country (2017-2028)
    Figure 37. Middle East and Africa Antidote Revenue Market Share by Type (2017-2022)
    Figure 38. Middle East and Africa Antidote Revenue Market Share by Application (2017-2022)
    Figure 39. Antidote Supply Chain (Upstream and Downstream Market)
    Figure 40. Global Production Market Share of Antidote Raw Materials by Region in 2021
    Figure 41. Antidote Distribution Channels
    Figure 42. Global Antidote Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 43. Global Antidote Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 44. Bottom-up and Top-down Approaches for This Report
    Figure 45. Data Triangulation
    Figure 46. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network
SIMILAR REPORTS